These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29362254)

  • 1. Incremental predictive value of screening for anxiety and depression beyond current type 2 diabetes risk models: a prospective cohort study.
    Atlantis E; Ghassem Pour S; Girosi F
    BMJ Open; 2018 Jan; 8(1):e018255. PubMed ID: 29362254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of serum testosterone for type 2 diabetes risk assessment in men.
    Atlantis E; Fahey P; Martin S; O'Loughlin P; Taylor AW; Adams RJ; Shi Z; Wittert G
    BMC Endocr Disord; 2016 May; 16(1):26. PubMed ID: 27230668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 10-item Kessler psychological distress scale (K10) as a screening instrument in older individuals.
    Anderson TM; Sunderland M; Andrews G; Titov N; Dear BF; Sachdev PS
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):596-606. PubMed ID: 23567398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening instruments for a population of older adults: The 10-item Kessler Psychological Distress Scale (K10) and the 7-item Generalized Anxiety Disorder Scale (GAD-7).
    Vasiliadis HM; Chudzinski V; Gontijo-Guerra S; Préville M
    Psychiatry Res; 2015 Jul; 228(1):89-94. PubMed ID: 25956759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The psychometric properties of the 10-item Kessler Psychological Distress Scale (K10) in Canadian military personnel.
    Sampasa-Kanyinga H; Zamorski MA; Colman I
    PLoS One; 2018; 13(4):e0196562. PubMed ID: 29698459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity of the Dutch K10 and extended K10 screening scales for depressive and anxiety disorders.
    Donker T; Comijs H; Cuijpers P; Terluin B; Nolen W; Zitman F; Penninx B
    Psychiatry Res; 2010 Mar; 176(1):45-50. PubMed ID: 20071036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening performance of K6/K10 and other screening instruments for mood and anxiety disorders in Japan.
    Sakurai K; Nishi A; Kondo K; Yanagida K; Kawakami N
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):434-41. PubMed ID: 21851452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for depressive and anxiety disorders among adolescents in Indonesia: Formal validation of the centre for epidemiologic studies depression scale - revised and the Kessler psychological distress scale.
    Tran TD; Kaligis F; Wiguna T; Willenberg L; Nguyen HTM; Luchters S; Azzopardi P; Fisher J
    J Affect Disord; 2019 Mar; 246():189-194. PubMed ID: 30583144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should psychological distress screening in the community account for self-perceived health status?
    Schmitz N; Lesage A; Wang J
    Can J Psychiatry; 2009 Aug; 54(8):526-33. PubMed ID: 19726005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comorbid depressive and anxiety symptoms and the risk of type 2 diabetes: Findings from the Lifelines Cohort Study.
    Deschênes SS; Burns RJ; Schmitz N
    J Affect Disord; 2018 Oct; 238():24-31. PubMed ID: 29852343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial.
    Paddison CA; Eborall HC; French DP; Kinmonth AL; Prevost AT; Griffin SJ; Sutton S
    Br J Health Psychol; 2011 Feb; 16(Pt 1):213-26. PubMed ID: 21226792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiety and depression symptoms in patients with diabetes.
    Collins MM; Corcoran P; Perry IJ
    Diabet Med; 2009 Feb; 26(2):153-61. PubMed ID: 19236618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
    Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
    BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The performance of the K10, K6 and GHQ-12 to screen for present state DSM-IV disorders among disability claimants.
    Cornelius BL; Groothoff JW; van der Klink JJ; Brouwer S
    BMC Public Health; 2013 Feb; 13():128. PubMed ID: 23402478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of the Diabetes Anxiety Depression Scale in Type 2 diabetes mellitus: The Fremantle Diabetes Study Phase II.
    Davis WA; Bruce DG; Dragovic M; Davis TME; Starkstein SE
    PLoS One; 2018; 13(3):e0194417. PubMed ID: 29543862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the prevalence of DSM-IV mental illness in the Australian general population using the Kessler Psychological Distress Scale.
    Sunderland M; Slade T; Stewart G; Andrews G
    Aust N Z J Psychiatry; 2011 Oct; 45(10):880-9. PubMed ID: 21875309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychometric properties of the K10 and K6 scales in screening for mood and anxiety disorders in the South African Stress and Health study.
    Andersen LS; Grimsrud A; Myer L; Williams DR; Stein DJ; Seedat S
    Int J Methods Psychiatr Res; 2011 Dec; 20(4):215-23. PubMed ID: 22113964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study.
    Wilkinson L; Yi N; Mehta T; Judd S; Garvey WT
    PLoS Med; 2020 Aug; 17(8):e1003232. PubMed ID: 32764746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fruit and vegetable consumption and psychological distress: cross-sectional and longitudinal analyses based on a large Australian sample.
    Nguyen B; Ding D; Mihrshahi S
    BMJ Open; 2017 Mar; 7(3):e014201. PubMed ID: 28298322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of depressive and anxiety disorders and validation of the Hospital Anxiety and Depression Scale as a screening tool in axial spondyloarthritis patients.
    Chan CYY; Tsang HHL; Lau CS; Chung HY
    Int J Rheum Dis; 2017 Mar; 20(3):317-325. PubMed ID: 25293872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.